Literature DB >> 33841797

Characteristics of Japanese elderly patients with pulmonary arterial hypertension.

Yukiko Takahashi1, Keiko Yamamoto1, Nobuhiro Tanabe1,2, Rika Suda1, Ken Koshikawa1, Yumiko Ikubo1, Eiko Suzuki1, Hiroki Shoji1, Akira Naito1, Hajime Kasai1, Rintaro Nishimura1, Takayuki Jujo Sanada1, Toshihiko Sugiura1, Ayako Shigeta1, Seiichiro Sakao1, Koichiro Tatsumi1.   

Abstract

Previous nationwide Japanese data suggested that pulmonary arterial hypertension (PAH) predominantly affects young women. However, the number of elderly patients diagnosed with PAH has been increasing in western countries. There have been no reports on elderly PAH patients in Asian countries. This study aimed to investigate the clinical characteristics of elderly PAH patients in a Japanese cohort. Idiopathic/heritable PAH (I/H-PAH) was included in the national research project on intractable diseases. The patients were required to submit a clinical research form completed by their attending physicians. We analyzed the characteristics of Japanese I/H-PAH using the newly registered forms in 2013 (Study 1, n = 148). Also, we did a retrospective, observational cohort study at Chiba University Hospital (Study 2, n = 42). We compared the characteristics of elderly PAH patients (≥65 years old) with younger patients (<65) in both studies. Study 1 revealed a predominance of males (51% male), better hemodynamics and poorer exercise capacity in the elderly group (n = 72), compared with the younger group (n = 76) in study 1. In Study 2, elderly patients showed a male predominance (63% male), a higher ratio of smokers, a lower % carbon monoxide diffusing capacity, and poorer exercise tolerance. Elderly patients in Study 2 showed less improvement in hemodynamics with therapy. There was no significant difference in disease-specific survival between elderly and younger patients. Japanese elderly patients with I/H-PAH showed poorer exercise capacity and impaired gas exchange, but better pulmonary hemodynamics than younger patients.
© The Author(s) 2020.

Entities:  

Keywords:  IPAH; elderly PAH; pulmonary arterial hypertension

Year:  2020        PMID: 33841797      PMCID: PMC7841872          DOI: 10.1177/2045894019873546

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  22 in total

1.  Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.

Authors:  Athénaïs Boucly; Jason Weatherald; Laurent Savale; Xavier Jaïs; Vincent Cottin; Grégoire Prevot; François Picard; Pascal de Groote; Mitja Jevnikar; Emmanuel Bergot; Ari Chaouat; Céline Chabanne; Arnaud Bourdin; Florence Parent; David Montani; Gérald Simonneau; Marc Humbert; Olivier Sitbon
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

2.  Pulmonary arterial hypertension in France: results from a national registry.

Authors:  Marc Humbert; Olivier Sitbon; Ari Chaouat; Michèle Bertocchi; Gilbert Habib; Virginie Gressin; Azzedine Yaici; Emmanuel Weitzenblum; Jean-François Cordier; François Chabot; Claire Dromer; Christophe Pison; Martine Reynaud-Gaubert; Alain Haloun; Marcel Laurent; Eric Hachulla; Gérald Simonneau
Journal:  Am J Respir Crit Care Med       Date:  2006-02-02       Impact factor: 21.405

3.  Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension.

Authors:  Clara Hjalmarsson; Göran Rådegran; David Kylhammar; Bengt Rundqvist; Jonas Multing; Magnus D Nisell; Barbro Kjellström
Journal:  Eur Respir J       Date:  2018-05-03       Impact factor: 16.671

Review 4.  Pulmonary Hypertension.

Authors:  Marius M Hoeper; Hossein-Ardeschir Ghofrani; Ekkehard Grünig; Hans Klose; Horst Olschewski; Stephan Rosenkranz
Journal:  Dtsch Arztebl Int       Date:  2017-02-03       Impact factor: 5.594

5.  Prediction of life expectancy in patients with primary pulmonary hypertension. A retrospective nationwide survey from 1980-1990.

Authors:  O Okada; N Tanabe; J Yasuda; Y Yoshida; K Katoh; T Yamamoto; T Kuriyama
Journal:  Intern Med       Date:  1999-01       Impact factor: 1.271

6.  A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension.

Authors:  David Kylhammar; Barbro Kjellström; Clara Hjalmarsson; Kjell Jansson; Magnus Nisell; Stefan Söderberg; Gerhard Wikström; Göran Rådegran
Journal:  Eur Heart J       Date:  2018-12-14       Impact factor: 29.983

7.  Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.

Authors:  David B Badesch; Gary E Raskob; C Greg Elliott; Abby M Krichman; Harrison W Farber; Adaani E Frost; Robyn J Barst; Raymond L Benza; Theodore G Liou; Michelle Turner; Scott Giles; Kathy Feldkircher; Dave P Miller; Michael D McGoon
Journal:  Chest       Date:  2009-10-16       Impact factor: 9.410

8.  Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.

Authors:  Nazzareno Galiè; Joan A Barberà; Adaani E Frost; Hossein-Ardeschir Ghofrani; Marius M Hoeper; Vallerie V McLaughlin; Andrew J Peacock; Gérald Simonneau; Jean-Luc Vachiery; Ekkehard Grünig; Ronald J Oudiz; Anton Vonk-Noordegraaf; R James White; Christiana Blair; Hunter Gillies; Karen L Miller; Julia H N Harris; Jonathan Langley; Lewis J Rubin
Journal:  N Engl J Med       Date:  2015-08-27       Impact factor: 91.245

9.  Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

Authors:  G E D'Alonzo; R J Barst; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; J T Kernis
Journal:  Ann Intern Med       Date:  1991-09-01       Impact factor: 25.391

Review 10.  Pulmonary hypertension in the elderly: a different disease?

Authors:  Grégory Berra; Stéphane Noble; Paola M Soccal; Maurice Beghetti; Frédéric Lador
Journal:  Breathe (Sheff)       Date:  2016-03
View more
  1 in total

1.  The impact of cardiovascular comorbidities associated with risk for left heart disease on idiopathic pulmonary arterial hypertension: Data from the Hellenic Pulmonary Hypertension Registry (HOPE).

Authors:  Alexandra Arvanitaki; Elena Vrana; Maria Boutsikou; Anastasia Anthi; Sotiria Apostolopoulou; Aikaterini Avgeropoulou; Eftychia Demerouti; Alexandros Patrianakos; Panagiotis Karyofyllis; Ioanna Mitrouska; Sophia A Mouratoglou; Katerina K Naka; Stylianos E Orfanos; Evangelia Panagiotidou; Georgia Pitsiou; Spyridon Rammos; Ioannis Stanopoulos; Adina Thomaidi; Alexandra Frogoudaki; Afroditi Boutou; George Anastasiadis; Styliani Brili; Iraklis Tsangaris; Dimitrios Tsiapras; Vassilios Voudris; Athanasios Manginas; George Giannakoulas
Journal:  Pulm Circ       Date:  2022-06-07       Impact factor: 2.886

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.